---
document_datetime: 2023-09-21 20:17:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/fintepla-epar-all-authorised-presentations_en.pdf
document_name: fintepla-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9507815
conversion_datetime: 2025-12-21 22:34:23.518965
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                                              |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|------------------------------------------------------------------------|
| EU/1/20/1491/001 | Fintepla          | 2.2 mg/ml  | Oral solution         | Oral use                  | bottle (HDPE)         | 60 ml                     | 1 bottle + 4 oral syringes of 3 ml + 1 bottle adapter                  |
| EU/1/20/1491/002 | Fintepla          | 2.2 mg/ml  | Oral solution         | Oral use                  | bottle (HDPE)         | 120 ml                    | 1 bottle + 4 oral syringes of 3 ml +                                   |
| EU/1/20/1491/003 | Fintepla          | 2.2 mg/ml  | Oral solution         | Oral use                  | bottle (HDPE)         | 250 ml                    | 1 bottle adapter 1 bottle + 4 oral syringes of 6 ml + 1 bottle adapter |
| EU/1/20/1491/004 | Fintepla          | 2.2 mg/ml  | Oral solution         | Oral use                  | bottle (HDPE)         | 360 ml                    | 1 bottle + 4 oral syringes of 6 ml + 1 bottle adapter                  |